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Abstract 
Background: Keloid and hypertrophic scars (HTS) caused by an imbalance between the production and 
destruction of collagen during wound healing with an unknown underlying pathophysiological mechanism. This 
study was designed to evaluate the histamine level in the Keloid and HTS and comparison of results with normal 
skin. 
Materials and Methods: This pilot study included 36 participants, aged from 18 to 70 years with keloid (n=11), 
HTS (n=13) and normal (n=12) skin. The level of histamine in the skin samples was measured using enzyme-
linked immunosorbent assay (ELISA). 
Results: Histamine level in keloid samples was significantly higher than in the normal (p=0.0012) or HTS 
(p=0.0028) groups. However, there was no significant difference between the normal and HTS samples 
(p=0.92). 
Conclusion: The increased histamine level in the keloid tissue may contribute to its pathogenesis and the 
application of anti-histamines could be of benefit for the prevention and treatment of keloids. 
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Introduction 
Keloid and hypertrophic scars (HTS) are two types of 
scars with complex pathogenesis. These two kinds of 
scar differ pathologically and each needs different 
therapeutic approaches. The current treatments are not 
fully effective and cause irreversible side effects. The 
poorly defined underlying mechanism is an obstacle 
for the development of new treatments. Both keloid 
and HTS are the results of deregulation of normal 
wound healing ending with excessive extracellular 
matrix production and fibrin deposition. Mast cells and 
their mediators are involved in different phases of 
wound healing1. Some data have shown that mast cells 
are increased in the scar tissue2. Their number or 
activation has also been stated to be lower in tissues that 
heal with minimal scarring1. Administration of mast 
cell inhibitor, disodium cromoglycate, to mice 
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decreases the scar and inflammation. Histamine is a 
biogenic amine mainly released from mast cells and 
acts on four main histamine receptors (H1-H2) 
belonging to the G protein-coupled receptor 
superfamily.  
Histamine enhances vasodilation and capillary 
permeability resulting in the influx of neutrophils. It 
supports the growth and differentiation of fibroblasts 
and collagen synthesis1. Several studies have 
suggested the use of anti-histamines for scar 
treatment. However, there is not any data regarding 
the concentration of histamine in any kind of scar. 
This study was designed to evaluate the histamine 
level in keloid and HTS. 
Methods 
The present study was a descriptive cross‐sectional 
study, which was carried out on 36 patients (18-70 
years old) with keloid (n=11), HTS (n=13), or normal 
skin (n=12) who were referred to Modarres and 15 
Khordad Hospital, Tehran, Iran, from September 2016 
to 2017. The ethical committee of the Shahid Beheshti 
University of Medical Sciences approved this study 
(IR.SBMU.RETECH.REC.1397.564) and all 
participants signed the informed consent form. The 
study was in accordance with the Declaration of 
Helsinki and the Medical Research Involving Human 
Subjects Act. 
The exclusion criteria were 1) history of any cancer or 
severe systemic disease; 2) current treatment with 
chemotherapy or immunosuppressive drugs; 3) 
pregnancy or breastfeeding; 4) any treatment for scar 
within the past two months. The samples of the scar 
tissue were isolated from the center of the lesion. The 
tissue samples were then cut into small pieces, and then 
an equal amount of all tissue samples were removed and 
mixed with a certain volume of PBS (pH 7.4, 100mM). 
Thereafter, all tissue specimens were homogenized and 
centrifuged at 4000 rpm for 10 min to obtain their 
supernatants. The level of histamine was measured in 
supernatants in duplicate using a commercial enzyme-
linked immunosorbent assay (ELISA) kit (Human 
histamine, ZellBio GmbH, Germany; Cat No: ZB-
11552C-H9648). The ordinary one-way analyses of 
variances with Tukey test was used to compare the 
means (GraphPad Prism software version 8.0.2). A p 
value of 0˂0.05 was considered as significant level. 
Results 
Histamine level was significantly different among the 
groups (F (2, 33)=9.297, p=0.0006). The concentration 
of histamine in keloid (54.69±7.36, mean ± SD) was 
significantly higher than normal (43.4±7.33, p=0.0012) 
and HTS (44.44±6.08, p=0.0028) tissue specimens. 
There was no significant difference in the levels of 
 
Figure 1. Histamine concentration (ng/ml) in normal, HTS, and keloid groups. All data are shown as mean ± SD; ** and P˂0.05 was 
considered statistically significant. 
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histamine between the normal and HTS groups 
(p=0.92) (Fig. 1). Demographic features of the 
patients are shown in Table 1. 
Discussion 
Histamine level was significantly increased in keloid 
tissue compared with HTS and normal skin samples. 
This increased level may be related to the increased 
number or activity of mast cells. The results are in line 
with a study conducted by Wilgus et al.,2 in which 
they reported the increased number of mast cells in 
scar tissues. Their number or activation has also been 
found to be lower in tissues undergoing scar-less 
healing than those that heal with more fibrotic scars1. 
Cutaneous wound healing in the fetus at early stages 
of development, unlike the mature skin, is not 
accompanied by inflammation. The number of mast 
cells in fetal wounds in embryonic day 15 mice 
showed to be nearly half of those in embryonic day 18 
mice. They also have smaller size with fewer granules. 
Additionally, injection of lysate obtained from cultured 
skin mast cells of embryonic day 18 mice to wounds of 
fetuses with embryonic day 15 resulted in the formation 
of the scar while administration of lysate from 
embryonic day 15 mice to embryonic day 18 mice led 
to scarless results3.  
Production of scar significantly is reduced in mast cell-
deficient mice in comparison to wild type animals3. 
Mast cells have histamine-containing granules that are 
responsible for many of their functions1. Mast cell 
inhibitors effectively decrease scar formation in mice 
while the rate of wound repair is not affected. H2 
receptor antagonists are found to block collagen 
production in cultured keloid fibroblasts4. Interestingly, 
histamine has a key role in endothelial cells 
proliferation and angiogenesis by activating H1 and H2 
Table 1: Demographic characteristics of patients. 




















>0.05 27.16 ± 2.17 23 ± 1.76 35.9 ± 3.93 Age, year (mean ± SD) 
 
 Neck (8, 66.7%) 
Arm (1, 8.3%) 
Elbow (2, 16.7%) 
Abdomen (1, 8.3%) 
 
Face (1, 7.7%) 
Neck (8, 61.5%) 
Hand (1, 7.7%) 
Arm (2, 15.4%) 
Lumbar (1, 7.7%) 
 
Neck (2, 18.1%) 
Hand (2, 18.1%) 
Arm (2, 18.1%)  
Sternum (4, 36.7%) 
Leg (1, 9%) 
 
Scar site (n, %) 
  Flame (9, 69.23%) Flame (5, 45.5%) Etiology (n, %) 
  Trauma (3, 23.07%) Trauma (5, 45.5%)  
  Chemical (1, 7.7%) Spontaneous (1, 9%)  
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receptors, which may be contributing to the keloid 
formation. The number of vessels and level of 
vascular endothelial growth factor is significantly 
higher in keloids than in normal skin5. The histamine 
level is significantly higher in keloids compared to 
HTS or normal skins. 
Conclusion 
Our data suggest the deed for conducting an 
interventional study to examine the potential impact 
of the use of topical anti-histamines for the prevention 
and treatment of keloids. Further investigations are 
needed to unravel the type of anti-histamine receptors 
that contribute to the scar formation. 
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